Samarth Kulkarni

Chief Executive Officer

Samarth Kulkarni (Chief Executive Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in CRISPR Therapeutics AG (CRSP). The largest single filing was $5.2M of CRSP (90,000 sh across 3 lots, as filed), executed Jan 20.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 7 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$10.8M

shares × price, as filed

Last traded

Mar 23

Filed Mar 24

Median ADV $94.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $17.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names

CRSP

CRISPR Therapeutics AG CRSP · 0 buys · 15 sells 15 filings

Recent filings

CRSPSALE CRISPR Therapeutics AG View filing → $414K
10,031 sh × $41.23
Exec Mar 21 2025
Filed Mar 24 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $616K
14,435 sh across 2 lots
Exec Mar 11 2025
Filed Mar 12 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $1.0M
18,360 sh × $55.21
Exec Feb 19 2025
Filed Feb 21 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $1.0M
18,568 sh across 2 lots
Exec Feb 18 2025
Filed Feb 19 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $826K
15,000 sh × $55.10
Exec Dec 2 2024
Filed Dec 4 2024 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $1.7M
30,000 sh across 2 lots
Exec Nov 11 2024
Filed Nov 13 2024 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $199K
4,293 sh × $46.28
Exec Oct 14 2024
Filed Oct 15 2024 · 5:30 PM ET